Corrigendum: Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study
Главные авторы: | Thomas Nyström, Irene Santos-Pardo, Fredric Hedberg, Johan Wardell, Nils Witt, Yang Cao, Leif Bojö, Bo Nilsson, Johan Jendle |
---|---|
Формат: | Статья |
Язык: | English |
Опубликовано: |
Frontiers Media S.A.
2018-02-01
|
Серии: | Frontiers in Endocrinology |
Предметы: | |
Online-ссылка: | http://journal.frontiersin.org/article/10.3389/fendo.2018.00050/full |
Схожие документы
-
Effects on Subclinical Heart Failure in Type 2 Diabetic Subjects on Liraglutide Treatment vs. Glimepiride Both in Combination with Metformin: A Randomized Open Parallel-Group Study
по: Thomas Nyström, и др.
Опубликовано: (2017-11-01) -
Pharmacometabolomic profiles in type 2 diabetic subjects treated with liraglutide or glimepiride
по: J. Jendle, и др.
Опубликовано: (2021-12-01) -
Glimepiride Compared to Liraglutide Increases Plasma Levels of miR-206, miR-182-5p, and miR-766-3p in Type 2 Diabetes Mellitus: A Randomized Controlled Trial
по: Nikolai N. Scherbak, и др.
Опубликовано: (2023-09-01) -
Liraglutide overdose: A case report and an updated review
по: Sharafaldeen Bin Nafisah, и др.
Опубликовано: (2020-01-01) -
Metformin exerts synergistic anti-proliferative effects with Liraglutide in human umbilical vein endothelial cells (HUVECs)
по: Amir Shadboorestan, и др.
Опубликовано: (2022-04-01)